0001567619-19-022075.txt : 20191122 0001567619-19-022075.hdr.sgml : 20191122 20191122160729 ACCESSION NUMBER: 0001567619-19-022075 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191122 DATE AS OF CHANGE: 20191122 EFFECTIVENESS DATE: 20191122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NERVGEN PHARMA CORP. CENTRAL INDEX KEY: 0001751912 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-354075 FILM NUMBER: 191241599 BUSINESS ADDRESS: STREET 1: SUITE 1703 - 595 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V7X 1J1 BUSINESS PHONE: 6047225361 MAIL ADDRESS: STREET 1: SUITE 1703 - 595 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V7X 1J1 D 1 primary_doc.xml X0708 D LIVE 0001751912 NERVGEN PHARMA CORP. SUITE 1703 - 595 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V7X 1J1 604-722-5361 BRITISH COLUMBIA, CANADA None None Corporation true 2017 Ernest Wong Three Bentall Centre, Suite 1703 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Executive Officer Director Robert Pilz Suite 1703-595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Executive Officer Amy Franke Suite 1703-595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Executive Officer Denis Bosc Suite 1703-595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Executive Officer Bill Radvak Suite 1703-595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Executive Officer Director Michael Abrams Suite 1703-595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Brian Bayley Suite 1703-595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Harold Punnett Suite 1703-595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Other Decline to Disclose 06b false 2019-11-15 false true false 0 1500000 1500000 0 Deemed value of shares issued in partial satisfaction of deposit for purchase price of goods. No cash proceeds raised. false 1 0 0 0 false NERVGEN PHARMA CORP. /s/ Robert Pilz Robert Pilz Chief Financial Officer 2019-11-22